About Company
CancerFree Biotech focuses on the use of Circulating Tumor Cells-Derived Organoid (CDO) culture system for a personalized analysis. We can rapidly amplify CTCs and develop an optimized anticancer strategy from the currently available anticancer drugs through low-risk and convenient liquid biopsy and biomimetic organoid culture system. Our platform also helping the pharma company or academic to do the drug discovery, become per-clinical anti-cancer drug development test platform.
Product Info
1.Product Concept:
CancerFree Biotech has a patented bionic tumor culture system to build patient-derived organoids (PDO). With this PDO model as an avatar, it helps physicians and patients develop the optimal treatment strategy to fight cancer at all stages which reduces the chance of clinical ineffective drug use and unnecessary toxicity.
2.Product Technical:
E.V.A. is a technology platform that we have developed to combine organoid culture systems and AI image recognition to rapidly expand CTCs into CDO for many applications in cancer research, such as cell therapy, cancer vaccine and new drug development.
3.ProductSolution:
CancerFree Biotech is the first commercialized in-vitro tumor cell culture platform from liquid biopsy. Current cancer treatment is based on standard treatment protocols and physician experience, but individual differences make treatment methods work differently for each patient. Through our platform E.V.A. (Ex-Vivo Avatar), doctors will know the actual effect of drugs on patients' cancer cells, and can further tailor treatment to patients' conditions, reducing the risk of patients trying drugs on themselves and reducing the risk and cost of potential ineffective drugs.
Product Solutions
Product Image
